Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Rajtar

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Acta Poloniae Pharmaceutica|January 1, 1996
Synthesis, chemical and pharmacological properties of some 2,4-dioxo-1,2,3,4,5,6,7,8-octahydropyrimido [4,5-d]pyrimidinesH Sladowska, M Sieklucka-Dziuba, G Rajtar, et al.
Farmaco (Societa Chimica Italiana : 1989)|November 1, 1995
Synthesis and biological evaluation of 7-azaanalogues of ipsapironeW Malinka, M Sielklucka-Dziuba, G Rajtar, et al.
Acta Poloniae Pharmaceutica|January 1, 1994
Acute and chronic toxicity of "Polfa" perphenazineZ Kleinrok, M Sieklucka-Dziuba, G Rajtar, et al.
Farmaco (Societa Chimica Italiana : 1989)|February 11, 2000
Investigations on the synthesis and pharmacological properties of amides of 7-methyl-3-phenyl-1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-2,4- dioxo-1,2,3,4-tetrahydropyrido[2,3-d]-pyrimidine-5-carboxylic acidH Sladowska, M Sieklucka-Dziuba, G Rajtar, et al.
Farmaco (Societa Chimica Italiana : 1989)|August 12, 1999
Synthesis and pharmacological screening of some N-(4-substituted-piperazin-1-ylalkyl)-3,4-pyrroledicarboximidesW Malinka, M Sieklucka-Dziuba, G Rajtar, et al.
Die Pharmazie|July 25, 2000
Synthesis and preliminary screening of derivatives of 2-(4-arylpiperazin-1-ylalkyl)-3-oxoisothiazolo[5,4-b] pyridines as CNS and antimycobacterial agentsW Malinka, M Sieklucka-Dziuba, G Rajtar, et al.
Blood|June 1, 1991
Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinasesV Evangelista, G Rajtar, G de Gaetano, et al.
Acta Physiologica Polonica|September 1, 1987
Comparison of pharmacological properties of rubidomycine and its newly synthesized derivatives DR-22 and DR-27 in animalsZ Kleinrok, B Chmielewska, D Chibowski, et al.
Farmaco (Societa Chimica Italiana : 1989)|January 1, 1995
Synthesis and pharmacological study of some derivatives of pyrazolo[4,3-c]pyrido[3,2-c]-1,2-thiazine-5,5-dioxide, a novel heterocyclic ring systemW Malinka, M Sieklucka-Dziuba, G Rajtar-Cynke, et al.
Farmaco (Societa Chimica Italiana : 1989)|December 1, 1994
Studies on synthesis and biological properties of pyrazolo[4,3-c]-pyrido[3,2-e]-1,2-thiazine-5,5-dioxide bearing 4-substituted-1-piperazinylpropyl moietyW Malinka, M Sieklucka-Dziuba, G Rajtar-Cynke, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Acta Poloniae Pharmaceutica|January 1, 1996
Synthesis, chemical and pharmacological properties of some 2,4-dioxo-1,2,3,4,5,6,7,8-octahydropyrimido [4,5-d]pyrimidinesH Sladowska, M Sieklucka-Dziuba, G Rajtar, et al.
Farmaco (Societa Chimica Italiana : 1989)|November 1, 1995
Synthesis and biological evaluation of 7-azaanalogues of ipsapironeW Malinka, M Sielklucka-Dziuba, G Rajtar, et al.
Acta Poloniae Pharmaceutica|January 1, 1994
Acute and chronic toxicity of "Polfa" perphenazineZ Kleinrok, M Sieklucka-Dziuba, G Rajtar, et al.
Farmaco (Societa Chimica Italiana : 1989)|February 11, 2000
Investigations on the synthesis and pharmacological properties of amides of 7-methyl-3-phenyl-1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-2,4- dioxo-1,2,3,4-tetrahydropyrido[2,3-d]-pyrimidine-5-carboxylic acidH Sladowska, M Sieklucka-Dziuba, G Rajtar, et al.
Farmaco (Societa Chimica Italiana : 1989)|August 12, 1999
Synthesis and pharmacological screening of some N-(4-substituted-piperazin-1-ylalkyl)-3,4-pyrroledicarboximidesW Malinka, M Sieklucka-Dziuba, G Rajtar, et al.
Die Pharmazie|July 25, 2000
Synthesis and preliminary screening of derivatives of 2-(4-arylpiperazin-1-ylalkyl)-3-oxoisothiazolo[5,4-b] pyridines as CNS and antimycobacterial agentsW Malinka, M Sieklucka-Dziuba, G Rajtar, et al.
Blood|June 1, 1991
Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinasesV Evangelista, G Rajtar, G de Gaetano, et al.
Acta Physiologica Polonica|September 1, 1987
Comparison of pharmacological properties of rubidomycine and its newly synthesized derivatives DR-22 and DR-27 in animalsZ Kleinrok, B Chmielewska, D Chibowski, et al.
Farmaco (Societa Chimica Italiana : 1989)|January 1, 1995
Synthesis and pharmacological study of some derivatives of pyrazolo[4,3-c]pyrido[3,2-c]-1,2-thiazine-5,5-dioxide, a novel heterocyclic ring systemW Malinka, M Sieklucka-Dziuba, G Rajtar-Cynke, et al.
Farmaco (Societa Chimica Italiana : 1989)|December 1, 1994
Studies on synthesis and biological properties of pyrazolo[4,3-c]-pyrido[3,2-e]-1,2-thiazine-5,5-dioxide bearing 4-substituted-1-piperazinylpropyl moietyW Malinka, M Sieklucka-Dziuba, G Rajtar-Cynke, et al.
Pageof 5